Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorLiberato, Marcelo Vizoná-
Autor(es): dc.creatorNascimento, Alessandro Silva-
Autor(es): dc.creatorAyers, Steven D.-
Autor(es): dc.creatorLin, Jean Z.-
Autor(es): dc.creatorCvoro, Aleksandra-
Autor(es): dc.creatorSilveira, Rodrigo Leandro-
Autor(es): dc.creatorMartínez, Leandro-
Autor(es): dc.creatorSouza, Paulo Cesar Telles de-
Autor(es): dc.creatorSaidemberg, Daniel Menezes-
Autor(es): dc.creatorDeng, Tuo-
Autor(es): dc.creatorAmato, Angélica Amorim-
Autor(es): dc.creatorTogashi, Marie-
Autor(es): dc.creatorHsueh, Willa Ann-
Autor(es): dc.creatorPhillips, Kevin-
Autor(es): dc.creatorPalma, Mário Sérgio-
Autor(es): dc.creatorNeves, Francisco de Assis Rocha-
Autor(es): dc.creatorSkaf, Munir Salomao-
Autor(es): dc.creatorWebb, Paul-
Autor(es): dc.creatorPolikarpov, Igor-
Data de aceite: dc.date.accessioned2021-10-14T17:59:09Z-
Data de disponibilização: dc.date.available2021-10-14T17:59:09Z-
Data de envio: dc.date.issued2013-05-30-
Data de envio: dc.date.issued2013-05-30-
Data de envio: dc.date.issued2012-05-
Fonte completa do material: dc.identifierhttp://repositorio.unb.br/handle/10482/13220-
Fonte completa do material: dc.identifierhttps://dx.doi.org/10.1371/journal.pone.0036297-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/620875-
Descrição: dc.descriptionABSTRACT-
Descrição: dc.descriptionThiazolidinediones (TZDs) act through peroxisome proliferator activated receptor (PPAR) γ to increase insulin sensitivity in type 2 diabetes (T2DM), but deleterious effects of these ligands mean that selective modulators with improved clinical profiles are needed. We obtained a crystal structure of PPARγ ligand binding domain (LBD) and found that the ligand binding pocket (LBP) is occupied by bacterial medium chain fatty acids (MCFAs). We verified that MCFAs (C8–C10) bind the PPARγ LBD in vitro and showed that they are low-potency partial agonists that display assay-specific actions relative to TZDs; they act as very weak partial agonists in transfections with PPARγ LBD, stronger partial agonists with full length PPARγ and exhibit full blockade of PPARγ phosphorylation by cyclin-dependent kinase 5 (cdk5), linked to reversal of adipose tissue insulin resistance. MCFAs that bind PPARγ also antagonize TZD-dependent adipogenesis in vitro. X-ray structure B-factor analysis and molecular dynamics (MD) simulations suggest that MCFAs weakly stabilize C-terminal activation helix (H) 12 relative to TZDs and this effect is highly dependent on chain length. By contrast, MCFAs preferentially stabilize the H2-H3/β-sheet region and the helix (H) 11-H12 loop relative to TZDs and we propose that MCFA assay-specific actions are linked to their unique binding mode and suggest that it may be possible to identify selective PPARγ modulators with useful clinical profiles among natural products.-
Formato: dc.formatapplication/pdf-
Publicador: dc.publisherPLOS-
Direitos: dc.rightsAcesso Aberto-
Direitos: dc.rightsPlos One - Este é um artigo de acesso aberto distribuído sob os termos da Licença Creative Commons Attribution, que permite uso irrestrito, distribuição e reprodução em qualquer meio, desde que o autor original e a fonte sejam creditados. Fonte: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0036297#abstract0. Acesso em: 29 maio 2013.-
Palavras-chave: dc.subjectÁcidos graxos-
Palavras-chave: dc.subjectInsulina-
Palavras-chave: dc.subjectFosforilação-
Título: dc.titleMedium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional – UNB

Não existem arquivos associados a este item.